Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 4
2009 5
2010 10
2011 7
2012 6
2013 7
2014 14
2015 8
2016 11
2017 8
2018 9
2019 5
2020 3
2021 3
2022 3
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

93 results

Results by year

Filters applied: . Clear all
Page 1
Under-reporting of harm in clinical trials.
Seruga B, Templeton AJ, Badillo FE, Ocana A, Amir E, Tannock IF. Seruga B, et al. Lancet Oncol. 2016 May;17(5):e209-19. doi: 10.1016/S1470-2045(16)00152-2. Epub 2016 Apr 27. Lancet Oncol. 2016. PMID: 27301048 Review.
Failures in Phase III: Causes and Consequences.
Seruga B, Ocana A, Amir E, Tannock IF. Seruga B, et al. Clin Cancer Res. 2015 Oct 15;21(20):4552-60. doi: 10.1158/1078-0432.CCR-15-0124. Clin Cancer Res. 2015. PMID: 26473191 Review.
Circulating DNA and Survival in Solid Tumors.
Ocaña A, Díez-González L, García-Olmo DC, Templeton AJ, Vera-Badillo F, José Escribano M, Serrano-Heras G, Corrales-Sánchez V, Seruga B, Andrés-Pretel F, Pandiella A, Amir E. Ocaña A, et al. Among authors: seruga b. Cancer Epidemiol Biomarkers Prev. 2016 Feb;25(2):399-406. doi: 10.1158/1055-9965.EPI-15-0893. Epub 2015 Nov 24. Cancer Epidemiol Biomarkers Prev. 2016. PMID: 26604269 Review.
Relevance of randomised controlled trials in oncology.
Tannock IF, Amir E, Booth CM, Niraula S, Ocana A, Seruga B, Templeton AJ, Vera-Badillo F. Tannock IF, et al. Among authors: seruga b. Lancet Oncol. 2016 Dec;17(12):e560-e567. doi: 10.1016/S1470-2045(16)30572-1. Lancet Oncol. 2016. PMID: 27924754 Review.
Fulvestrant for advanced breast cancer: a meta-analysis.
Al-Mubarak M, Sacher AG, Ocana A, Vera-Badillo F, Seruga B, Amir E. Al-Mubarak M, et al. Among authors: seruga b. Cancer Treat Rev. 2013 Nov;39(7):753-8. doi: 10.1016/j.ctrv.2013.03.004. Epub 2013 Jun 10. Cancer Treat Rev. 2013. PMID: 23764179 Review.
93 results